Acamprosate
- Level
- Commodity
- Parent
- 51143200
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51143204This classification denotes a neuroprotective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N4K14YGM3J. European Medicines Agency schedules Acamprosate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07366MIG. Acamprosate generally arises in the molecular formula C5H11NO4S. The term ACAMPROSATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, no. 3 1990, list 30.) ACAMPROSATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule acamprosate under HS 29241900 and SITC 51471. As of Q4 2014, ACAMPROSATE remains the US FDA Preferred Term for this commodity. Acamprosate bears US NLM identifiers UMLS ID C0284941 and NCI Concept Code C81691. SMILES: S(=O)(=O)(O)CCCNC(=O)C.
Same parent
Under 51143200 · 21Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.